The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload

Physics in Medicine and Biology

Volumn 45, Issue 5, 2000, Pages 1387-1396

  Farquharson, Michael J ^a   Bagshaw, Andrew P ^a   Porter, John B ^b   Abeysinghe, R D ^b  

^a CITY UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON DEXTRAN;

ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; BODY BURDEN; CALIBRATION; CHELATION; CONTROLLED STUDY; HEMOCHROMATOSIS; IRON OVERLOAD; NONHUMAN; PHANTOM; PRIORITY JOURNAL; RAT; X RAY FLUORESCENCE;

ANIMALS; BETA-THALASSEMIA; BIOPHYSICS; FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SPECTROMETRY, X-RAY EMISSION; TISSUE DISTRIBUTION;

EID: 0034115076     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/45/5/320     Document Type: Article

References (27)

1. Angelucci E, Giovagnoni A, Valeri G, Paci E, Ripalti M, Muretto P, McLaren C, Brittenham G M and Lucarelli G 1997 Limitations of magnetic resonance imaging in measurement of hepatic iron Blood 90 4736-42
2. Bassett M L, Leggett B A, Halliday J W, Webb S and Powell L W 1997 Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers J. Hepatol. 27 517-24
3. Bevington P R 1969 Data Reduction and Error Analysis for the Physical Sciences (New York: McGraw Hill)
4. Bonetti M G, Castriota-Scanderbeg A, Criconia G M, Mazza P, Sacco M, Amurri B and Masi C 1996 Hepatic iron overload in thalassaemic patients: proposal and validation of an MRI method of assessment Pediatr. Radiol. 26 650-6
5. Bonkovsky H L, Rubin R B, Cable E E, Davidoff A, Rijcken T H and Stark D D 1999 Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques Radiology 212 227-34
6. Brittenham G M, Farrell D E, Harris J W, Feldman E S, Danish E H, Muir W A, Tripp J H and Bellon E M 1982 Magnetic-susceptibility measurement of human iron stores New Engl. J. Med. 307 1671-5
7. Edwards C Q 1999 Hemochromatosis Wintrobe's Clinical Hematology vol 1, ed G R Lee, J Forester, J Lukens et al (Baltimore, MD: Williams and Wilkins)
8. Edwards C Q, Griffen L M, Goldgar D, Drummond C, Skolnick M H and Kushner J P 1988 Prevalence of hemochromatosis among 11 065 presumably healthy blood donors New Engl. J. Med. 318 1355-62
9. Farquharson M J and Bradley D A 1999 The feasibility of a sensitive low-dose method for the in vivo evaluation of Fe in the skin using K-shell x-ray fluorescence (XRF) Phys. Med. Biol. 44 955-65
10. Fischer R, Tiemann C D, Engelhardt R, Nielsen P, Durken M, Gabbe E E and Janka G E 1999 Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry Am. J. Hematol. 60 289-99
11. George E, Wong H B, George R and Arrifin W A 1994 Serum ferritin concentrations in transfusion dependent beta-thalassaemia Singapore Med. J. 35 62-4
12. Gillmore I T, Burroughs A, Murray-Lyon I M, Williams R, Jenkins D and Hopkins A 1995 Indication, method and outcomes of percutaneous liver biopsy in England and Wales. An audit by the British Society of Gastroenterology and the Royal College of Physicians of London Gut 36 437-41
13. Gorodetsky R, Goldfarb A, Dagon I and Rachmilewitz E A 1985 Non-invasive analysis of iron and zinc levels in the skin of beta-thalassaemia major and intermedia J. Lab. Clin. Med. 105 44-51
14. Gorodetsky R, Loewenthal K, Goldfarb A and Rachmilewitz E A 1990 Evaluation of iron load and clearance in patients with β-thalassaemia Ann. NY Acad. Sci. 612 568-72
15. Green S, Bradley D A, Palethorpe J E, Mearmean D H, Chettle D R, Lewis A D, Mountford P J and Morgan W D 1993 An enhanced sensitivity K shell x-ray fluorescence technique for tibial lead determination Phys. Med. Biol. 38 389-96
16. Ito K, Mitchell D G, Gabata T, Hann H L, Kim P N, Fujita T, Awaya H, Honjo K and Matsunaga N 1999 Hepatocellular carcinoma: Association with increased iron deposition in the cirrhotic liver at MR imaging Radiology 212 235-40
17. Marquardt D W 1963 An algorithm for least squares estimation of non-linear parameters J. Soc. Ind. Appl. Math. 11 431-41
18. Mavrogeni S I, Maris T, Gouliamos A, Vlahos L and Kremastinos D T 1998 Myocardial iron deposition in beta-thalassaemia studied by magnetic resonance imaging Int. J. Card Imaging 14 117-22
19. McDonnell S M, Hover A, Gloe D, Ou C Y, Cogswell M E and GrummerStrawn L 1999 Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organisations in Springfield, Missouri Am. J. Med. 107 30-7
20. 109Cd K x-ray fluorescence measurements Phys. Med. Biol. 44 2263-73
21. Nielsen P, Fischer R, Engelhardt R, Tondury P, Gabbe E E and Janka G E 1995 Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with desferoxamine or deferiprone Br. J. Haematol. 91 827-33
22. Olivieri N F and Brittenham G M 1997 Iron chelating therapy and the treatment of thalassemia Blood 89 739-61
23. Papakonstantinou O, Kostaridou S, Maris T, Gouliamos A, Premetis E, Kouloulias V, Nakopoulou L and Kattamis C 1999 Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassaemia: impact of chronic hepatitis C on measurements J. Pediatr. Hematol. Oncol. 21 142-8
24. Porter J B 1996 Evaluation of new iron chelators for clinical use Acta Haematol. 95 13-25
25. Porter J B, Abeysinghe R D, Hoyes K P, Barra C, Huehns E R, Brooke P N, Blackwell M P, Arenteta M, Brittenham G, Singh S, Dobbin P and Hider R C 1993 Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site Br. J. Haematol. 85 159-68
26. Somervaille L J, Chettle D R and Scott M C 1985 in vivo measurement of lead in bone using x-ray fluorescence Phys. Med. Biol. 30 929-43
27. Torrance J D And Bothwell T H 1968 A simple technique for measuring storage iron concentrations in formalinized liver samples S. Afr. J. Med. Sci. 33 9-11